Knights Of Columbus Asset Advisors LLC Fibrogen Inc Transaction History

Knights Of Columbus Asset Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$18.57 - $35.68 $557,397 - $1.07 Million	-30,016 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $7,843 - $14,097	-253 Reduced 0.84%	30,016 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $1,706 - $2,252	-46 Reduced 0.15%	30,269 $1.12 Million
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $182,195 - $204,841	-4,502 Reduced 12.93%	30,315 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $179,786 - $236,421	5,520 Added 18.84%	34,817 $1.41 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $66,288 - $130,756	-2,845 Reduced 8.85%	29,297 $1.02 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $1.11 Million - $1.54 Million	32,142 New	32,142 $1.38 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.